Stock AGH ALTHEA GROUP HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Althea Group Holdings Limited

Equities

AGH

AU0000022774

Pharmaceuticals

Market Closed - Australian S.E.
Other stock markets
 02:10:11 2024-05-03 am EDT 		5-day change 1st Jan Change
0.03 AUD +3.45% Intraday chart for Althea Group Holdings Limited 0.00% -23.08%
Apr. 30 Althea Group Holdings Posts AU$8 Million in Cash Receipts in Fiscal Q3 MT
Apr. 22 Althea Group Signs Distribution Agreement with Symbion MT

Business Summary

Althea Group Holdings Limited is engaged in the manufacturing, sales and distribution of recreational cannabis products and cannabis-based medicines. The Company operates through three business units: Althea, MyAccess Clinics and Peak Processing Solutions. Althea and MyAccess Clinics service the international pharmaceutical cannabis market, whilst Peak Processing Solutions operates in the federally legal Canadian recreational cannabis market. The Company’s segments include the international pharmaceutical segment (Pharmaceutical Cannabis), the Canadian recreational segment (Recreational Cannabis) and the shared corporate services (Corporate). The Pharmaceutical Cannabis includes Althea, a brand of cannabis-based medicine. The Company’s Recreational Cannabis segment includes Peak Processing Solutions (Peak), a contract manufacturing organization which works with consumer-packaged goods companies to develop, manufacture, and distribute recreational cannabis products.

Sales per Business

AUD in Million2022Weight2023Weight Delta
Pharmaceutical Cannabis
59.9 %
- - 15 59.9 % -
Recreational Cannabis
39.4 %
- - 10 39.4 % -
Corporate
0.7 %
- - 0 0.7 % -

Sales per region

AUD in Million2022Weight2023Weight Delta
Australia
48.6 %
12 60.2 % 12 48.6 % -1.36%
Canada
39.3 %
9 45.4 % 10 39.3 % +5.86%
United Kingdom
11.6 %
2 10.0 % 3 11.6 % +40.69%
Germany
0.5 %
-- 0 0.5 % -
Ireland
0.1 %
-- 0 0.1 % -

Managers

Managers TitleAgeSince
Joshua Fegan FOU
 Founder 39 17-06-20
Robert Michael Meissner DFI
 Director of Finance/CFO 43 18-10-14
Patty Holmes COO
 Chief Operating Officer - -
Julia Maguire IRC
 Investor Relations Contact - -
Trevor Steinthal PRN
 Corporate Officer/Principal - -
Michael Kafrouni PRN
 Corporate Officer/Principal - -
David Sauer LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Alan M. Boyd BRD
 Director/Board Member - -
Andrew Newbold CHM
 Chairman - -
Joshua Fegan FOU
 Founder 39 17-06-20
Penelope Dobson BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 401,083,953 267,756,240 ( 66.76 %) 0 66.76 %

Shareholders

NameEquities%Valuation
Joshua Fegan
14.17 %
57,444,030 14.17 % 1 M $
Andrew Newbold
0.6943 %
2,814,269 0.6943 % 58 762 $
Alan M. Boyd
0.1400 %
567,436 0.1400 % 11 848 $

Company contact information

Althea Group Holdings Ltd.

360 Elizabeth Street Suite 2, Level 37

3000, Melbourne

+

http://www.althea.com.au
address Althea Group Holdings Limited(AGH)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ALTHEA GROUP HOLDINGS LIMITED Stock Althea Group Holdings Limited
-23.08% 8.14M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AGH Stock
  4. Company Althea Group Holdings Limited